Improving Knowledge and Awareness of Preventive Antibodies for RSV Infants and Young Children

Annenberg Center for Health Sciences
  • 5.0 (1)
  • MEDICINE

Respiratory syncytial virus (RSV) is a contagious respiratory infection and a leading cause of illness in children. This activity includes five conversations with experts in nursing, pediatrics, and neonatology. They review RSV basics, current immunoprophylaxis options, and tools to help clinicians prevent RSV in infants and young children, with detailed discussion of RSV antibodies, supporting evidence, and recommendations.

Episodes

  1. FEB 13

    Tools to Facilitate RSV Prevention

    Resources for CliniciansPractical Considerations

    7 min

  2. FEB 13

    Clinical Recommendations for RSV Prevention

    Organizational GuidanceInfants 8 MonthsInfants/Young Children 8-19 MonthsAntibody Administration

    13 min

  3. FEB 13

    RSV Immunoprophylaxis Strategies in Infants/Young Children

    Historical Use of PalivizumabBasics of RSV AntibodiesNirsevimabClesrovimab

    16 min

  4. FEB 13

    RSV Immunoprophylaxis Strategies in Pregnant Parents

    Pregnant Parent Vaccination (RSVpreF)

    9 min

  5. FEB 13

    RSV Infection in Infants/Children

    EpidemiologyMorbidity and MortalitySigns and SymptomsRisk FactorsAcute and Chronic Complications

    16 min
  • 5 Episodes

About

Respiratory syncytial virus (RSV) is a contagious respiratory infection and a leading cause of illness in children. This activity includes five conversations with experts in nursing, pediatrics, and neonatology. They review RSV basics, current immunoprophylaxis options, and tools to help clinicians prevent RSV in infants and young children, with detailed discussion of RSV antibodies, supporting evidence, and recommendations.

Information